Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mullol

Showing results (141-150 of 247) with videos related to

Pageof 25
Sort By:
Journal of Investigational Allergology & Clinical Immunology|October 21, 2016
Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study)R Munoz-Cano, E Ainsua-Enrich, I Torres-Atencio, et al.
Journal of Investigational Allergology & Clinical Immunology|May 30, 2009
Molecular diagnosis in allergology: application of the microarray techniqueM Ferrer, M L Sanz, J Sastre, et al.
Allergy|September 24, 2009
United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient's quality of lifeJ M Guilemany, J Angrill, I Alobid, et al.
Journal of Investigational Allergology & Clinical Immunology|February 23, 2023
Mepolizumab for Treatment of Severe Eosinophilic Asthma: A 5-Year Real-World ExperienceD Loli-Ausejo, G Perdomo, B Mascaró, et al.
Rhinology|December 11, 2024
Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthmaJ Mullol, V Backer, J Constantinidis, et al.
Archivos De Bronconeumologia|May 25, 2002
[Chronic cough]A De Diego Damiá, V Plaza Moral, V Garrigues Gil, et al.
Allergy|January 19, 2010
Endothelial L-selectin ligand expression in nasal polypsFenna A Ebbens, S K Toppila-Salmi, J A Renkonen, et al.
Rhinology|June 3, 2024
Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in SpainJ Mullol, J Sastre, J Dominguez-Ortega, et al.
Allergy|January 10, 2009
Topical glucocorticoids downregulate COX-1 positive cells in nasal polypsF A Ebbens, M Maldonado, E J J de Groot, et al.
Rhinology|April 1, 2020
Executive summary of EPOS 2020 including integrated care pathwaysW J Fokkens, V J Lund, C Hopkins, et al.
Pageof 25

Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Journal of Investigational Allergology & Clinical Immunology|October 21, 2016
Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study)R Munoz-Cano, E Ainsua-Enrich, I Torres-Atencio, et al.
Journal of Investigational Allergology & Clinical Immunology|May 30, 2009
Molecular diagnosis in allergology: application of the microarray techniqueM Ferrer, M L Sanz, J Sastre, et al.
Allergy|September 24, 2009
United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient's quality of lifeJ M Guilemany, J Angrill, I Alobid, et al.
Journal of Investigational Allergology & Clinical Immunology|February 23, 2023
Mepolizumab for Treatment of Severe Eosinophilic Asthma: A 5-Year Real-World ExperienceD Loli-Ausejo, G Perdomo, B Mascaró, et al.
Rhinology|December 11, 2024
Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthmaJ Mullol, V Backer, J Constantinidis, et al.
Archivos De Bronconeumologia|May 25, 2002
[Chronic cough]A De Diego Damiá, V Plaza Moral, V Garrigues Gil, et al.
Allergy|January 19, 2010
Endothelial L-selectin ligand expression in nasal polypsFenna A Ebbens, S K Toppila-Salmi, J A Renkonen, et al.
Rhinology|June 3, 2024
Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in SpainJ Mullol, J Sastre, J Dominguez-Ortega, et al.
Allergy|January 10, 2009
Topical glucocorticoids downregulate COX-1 positive cells in nasal polypsF A Ebbens, M Maldonado, E J J de Groot, et al.
Rhinology|April 1, 2020
Executive summary of EPOS 2020 including integrated care pathwaysW J Fokkens, V J Lund, C Hopkins, et al.
Pageof 25